ロード中...
Formulation and Evaluation of Transdermal Patch of Repaglinide
Repaglinide has the half life of 1 hour, and bioavailability in the body is 56% due to first-pass metabolism. The total daily dose of Repaglinide is 16 mg (e.g., 4 mg four times daily depending on meal patterns); hence, it required frequent dosing. Transdermal patch of Repaglinide was prepared to su...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Scholarly Research Network
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263722/ https://ncbi.nlm.nih.gov/pubmed/22389856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2011/651909 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|